AstraZeneca to invest $360 million in new Irish drug manufacturing site

- AstraZeneca said on Tuesday it would invest $360 million to develop an advanced manufacturing facility in Ireland to produce primary ingredients for medicines.

The Anglo-Swedish drugmaker, which completed its $39 billion purchase of rare disease drugs maker Alexion in July, has a large portfolio of treatments for cancer, heart disease, diabetes and a COVID-19 vaccine, with several drugs under trials.